Baseline measurements and results: Administrations with an administration error and potential risk of harm
| Control ward | Intervention ward | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline, n=19 | Post intervention, n=100 | Relative risk (CI95%) | Baseline, n=13 | Post intervention, n=59 | Relative risk (CI95%) | |||||||
| Medication errors | Administration error (%) | Potential risk of harm* (%) | Administration error (%) | Potential risk of harm* (%) | Administration error | Potential risk of harm* (%) | Administration error (%) | Potential risk of harm* (%) | Administration error (%) | Potential risk of harm* (%) | Administration error (%) | Potential risk of harm* (%) |
| Administrations with 1 or more errors (all) | 14 (74%) | 6 (32%) | 76 (76%) | 14 (14%) | 1,03 (0,77-1,38) | 0,45 (0,20-1,02) | 6 (46%) | 1 (8%) | 40 (68%) | 0 (0%) | 1,47 (0,80-2,71) | N/A |
| Wrong patient / drug / dose / dose form / administration route (all) | 0 (0%) | 0 (0%) | 0 (0%) | 0% (0%) | N/A | N/A | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | N/A | N/A |
| Wrong time (all) | 9 (47%) | 0 (0%) | 25 (25%) | 0 (0%) | N/A | N/A | 1 (8%) | 0 (0%) | 9 (15%) | 0 (0%) | N/A | N/A |
| Wrong duration (all) | 8 (42%) | 6 (32%) | 65 (65%) | 14 (14%) | 1,54 (0,89-2,67) | 0,44 (0,20-1,01) | 5 (38%) | 1 (8%) | 34 (58%) | 0 (0%) | 1,50 (0,72-3,08) | N/A |
| -Bolus injection (% of total bolus injections) | 8/14 (57%) | 6/14 (43%) | 35/46 (76%) | 13/46 (28%) | 1,33 (0,82-2,16) | 0,66 (0,31-1,41) | 2/3 (67%) | 1/3 (33%) | 6/13 (46%) | 0/13 (0%) | 0,69 (0,26-1,87) | N/A |
| -Infusion (% of total infusions) | 0/4 (0%) | N/A | 30/53 (57%) | 1/53 (2%) | N/A | N/A | 3/10 (30%) | 0/10 (0%) | 28/46 (61%) | 0/46 (0%) | 2,03 (0,77-5,38) | N/A |
| -Continuous infusion (% of total continuous infusions) | 0/1 (0%) | N/A | 0/1 (0%) | 0/1 (0%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
*NCC MERP category ≥ D
N/A; not applicable (a.o. due to value zero in cell)